PGY-2: Oncology

Hospital Information – Tisch Cancer Institute

U.S. News and World Report ranks Mount Sinai among the Top Cancer Hospitals in the United States. Our distinguished team offers the most advanced treatments for patients with all types of cancer. At The Tisch Cancer Institute, we provide multidisciplinary care including medical oncology, surgical oncology, and radiation oncology, as well as a full range of diagnostic and supportive care services. Our mission is to care for the “whole person,” not just to treat the disease. In addition to our multidisciplinary approach and comprehensive services, The Tisch Cancer Institute builds upon the exceptional medical and surgical care at Mount Sinai Hospital by providing access to cutting edge clinical trials for adults and children with cancer.

Our mission is to build upon Mount Sinai Hospital’s reputation for excellence in research and clinical care to find new ways to prevent, treat, and cure cancer. The Tisch Cancer Institute has access to levels of research expertise and patient care that few other cancer centers can offer. As the Tisch Cancer Institute continues to grow, we will implement new multidisciplinary programs and construct new buildings for patient care and scientific research. Nearly one-third of Mount Sinai’s strategic investments have been dedicated to cancer care and research- illustrating Mount Sinai’s commitment to fighting the disease. Additional services include screening, clinical trials, genetic counseling, psychosocial support, nutritional counseling, complementary medicine, and wellness counseling.

Oncology Residency Program Information

General Information
We accept one (1) full-time PGY 2 Oncology Resident each year for the 12 month residency. A major research project must be completed and presented during the residency year.

Purpose: The goal of the oncology residency program is to provide opportunities in direct patient care, administration, education, and research in various different oncology areas for the oncology resident to become a competent and independent clinical pharmacy specialist in oncology.

Objectives:

  • Develop the skills and competency necessary to function as an independent oncology pharmacist
  • Provide direct pharmaceutical care for cancer patients
  • Develop management and leadership skills
  • Educate other health care professionals and patients about chemotherapy
  • Develop a professional and ethical approach to daily activities

Program Description
The oncology pharmacy residency at Mount Sinai Hospital is ASHP-accredited and it is a twelve month program with a focus on oncology patient centered medication therapy management. The majority of the resident’s time will be spent on various oncology teams, working collaboratively with a medical team and other health care providers. The pharmacy resident will serve as a pharmacy resource within the team.

Benefits: Funding is available for educational meetings as well as membership in national, state, and local professional organizations. Residents receive an annual stipend and are eligible for health insurance, holidays and educational travel.
Vacation: 19 total days Paid Time Off (PTO)

Learning Experiences
Core Rotations (10 months)

  • Solid Tumor
  • Malignant Hematology
  • BMT (Allogeneic and Autologous)
  • Ambulatory Oncology
  • Oncology Clinical Trials
  • Oncology Drug Information

Elective Rotations (2 months)

  • Nutrition Support
  • Palliative Care
  • Transplant ID
  • Others (depending on resident’s area of interest)

Longitudinal Experiences

Drug Policy - Attendance at various interdisciplinary committee meetings as determined by the Program Director:

  • Oncology P &T Subcommittee
  • Tisch Cancer Institute PI Committee
  • BMT Clinical QA Committee
  • Chemotherapy Council
  • Drug Shortage Committee

Research

  • Protocol submission to IRB
  • Poster presentation at HOPA and Eastern States Residency conferences
  • Completed data presented to oncology group

Departmental Service

  • Weekend staffing (1st and 3rd Saturdays) in decentralized inpatient and ambulatory oncology satellites
  • Pharmacy Journal Club and Case Conferences
  • Pharmacy Grand Rounds
  • Performance Improvement
  • Pharmacy Manager’s Group

Current Oncology Pharmacy Resident
Chung-Shien Lee, Pharm D, BCPS

Past Oncology Pharmacy Residents
Class of 2012-2013
Monank Patel, Pharm D (Currently employed as a Clinical Pharmacist in Hematology/BMT at West Penn Allegheny Health System)

Class of 2011-2012
Kendra Yum, Pharm D (Currently employeed as a Clinical Pharmacy Coordinator in Oncology Clinical Trials at Mount Sinai Hospital)

How to Apply

Mount Sinai pharmacy residency programs utilize the Pharmacy Online Residency Centralized Application Service (PhORCAS) for ALL resident application submissions.

We require the following documents through the PhORCAS site as part of our application packet:

  • Curriculum vitae
  • Letter of interest
  • THREE letters of recommendation
  • ALL post-secondary transcripts, including pre-pharmacy coursework and prior degrees
  • Professional writing sample
  • Professional experience including average hours worked weekly

Qualifications of Applicants

  • Pharm D degree from an ACPE-accredited College of School of Pharmacy
  • Completion of an ASHP-accredited PGY1 residency of equivalent experience
  • Must be eligible for a NYS Pharmacy license and obtain an intern permit prior to starting the residency. ALL residents must become licensed in NYS by October of the residency year.

Contact Us

Program Director, PGY2 Oncology Residency
Sara S. Kim, BS, Pharm D, BCOP
Tel: 212-241-3617
Send e-mail

Department of Pharmacy
The Mount Sinai Hospital
One Gustave L. Levy Place
Box 1211
New York, NY 10029

Application Deadline: 
January 15, 2014